Insulet Corporation PODD continues to gain on solid prospects in the diabetes market. The company is progressing well with respect to its four-pillar strategy. However, the company’s heavy reliance on ...

Omnipod 5 has been a major revenue catalyst for Insulet since its release. At the same time, operating expenses associated with Omnipod 5 are higher because of demand exceeding expectations. Higher ...

Insulin pump-maker Insulet has scored FDA 510(k) clearance for its Omnipod 5 Automated Insulin Delivery System for people ages 6 and up with Type 1 diabetes. The pump integrates with the Dexcom G6 ...

Insulet has begun a voluntary recall of the remote-control devices used with its Omnipod Dash insulin pumps after discovering that the devices’ batteries may be at risk of swelling, leaking or ...

Insulet has secured an FDA clearance for its latest tubeless insulin pump, the Omnipod 5, a patch-like device capable of adjusting daily doses to changes in the wearer’s blood sugar levels. Designed ...

OKLAHOMA CITY — Medicaid recipients in Oklahoma who have diabetes may benefit from a proposed change in the way the state covers costs of automated insulin management systems. On Monday, lawmakers on ...

Insulet Corporation PODD continues to gain on solid prospects in the diabetes market. A tough competitive landscape raises concerns. The stock carries a Zacks Rank #3 (Hold). Over the past year, ...